I

In8bio, (INAB)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About In8bio, (INAB)

IN8bio, Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of gamma-delta T cell product candidates for solid and liquid tumors. Gamma-delta T cells are a specialized population of T ... Read more

Open
USD3.58
High
USD4.17
Low
USD2.85
52 Week High
USD52.20
Monthly Return
-15.10%
Revenue
--

Daily Vol.
528.25k
Avg. Daily Vol.
8.32M
Market Cap.
13M
52 Week Low
2.85
Annual Return
-87.70%

Stock News

Circle’s buzzy IPO was a big hit. Now comes the hard part.

Circle’s buzzy IPO was a big hit. Now comes the hard part.

MarketWatch

36-year-old sold her childhood home in Wisconsin to live and travel in a truck she spent $50,000 renovating: 'I don't have a single regret'

36-year-old sold her childhood home in Wisconsin to live and travel in a truck she spent $50,000 renovating: 'I don't have a single regret'

CNBC

Broadcom could blow past Nvidia, expert predicts

Broadcom could blow past Nvidia, expert predicts

Yahoo

Jobs, profit-taking and 2 other things that drove the stock market this week

Jobs, profit-taking and 2 other things that drove the stock market this week

CNBC

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.